tiprankstipranks
Amedisys Inc (DE:ADY)
FRANKFURT:ADY
Holding DE:ADY?
Track your performance easily

Amedisys (ADY) Income Statement

2 Followers

Amedisys Income Statement

Last quarter (Q3 2024), Amedisys's total revenue was $587.70M, an increase of 6.27% from the same quarter last year. In Q3, Amedisys's net income was $16.91M. See Amedisys’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.86B$ 2.24B$ 2.22B---
Cost of Revenue
$ 1.30B$ 1.25B$ 1.26B$ 1.23B$ 1.19B$ 1.15B
Gross Profit
$ 1.56B$ 990.87M$ 962.77M$ 980.76M$ 886.15M$ -1.15B
Operating Expense
$ 1.88B$ 797.81M$ 778.99M$ -1.50B$ -1.40B$ -1.35B
Operating Income
$ 158.70M$ 156.40M$ 180.80M$ 251.90M$ 219.30M$ 177.50M
Net Non Operating Interest Income Expense
$ 35.13M$ 28.00M$ 22.05M$ -9.53M$ -11.04M$ -14.52M
Other Income Expense
$ -229.46M$ -125.44M$ -1.49M$ -37.84M$ -2.59M$ -7.45M
Pretax Income
$ 145.36M$ 39.62M$ 160.24M$ 280.23M$ 210.82M$ 170.41M
Tax Provision
$ 51.64M$ 50.56M$ 42.55M$ 70.06M$ 25.64M$ 42.50M
Earnings From Equity Interest Net Of Tax
$ 6.05M$ 10.76M$ -45.00K$ 4.95M$ 3.97M$ 5.34M
Net Income Common Stockholders
$ 94.49M$ -9.75M$ 118.61M$ 209.07M$ 183.61M$ 163.68M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 896.56M$ 2.04B$ 2.04B$ -269.47M$ -217.83M$ -197.41M
Net Income From Continuing And Discontinued Operation
$ 94.49M$ -9.75M$ 118.61M$ 209.07M$ 183.61M$ 126.80M
Normalized Income
$ 107.41M-----
Interest Expense
------
EBIT
$ 189.24M$ 70.90M$ 182.47M$ 289.76M$ 221.86M$ 184.93M
EBITDA
$ 249.06M$ 128.74M$ 253.44M$ 361.02M$ 289.80M$ 240.13M
Currency in USD

Amedisys Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis